Goldman Still Neutral On ATHN


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Goldman Sachs has published a research report on athenahealth, Inc. (NASDAQ: ATHN) following the company's reporting of 3Q earnings results.In the report, Goldman Sachs writes "athenahealth delivered solid 3Q results; driving cost improvements (notably cost of sales and G&A) while tracking well on revenues. In our view, the strong positive stock reaction (+23% on Friday's session) was a result of a highly binary investor setup as well as 30% short interest. In our opinion, ATHN's 3Q further demonstrated management's ability to drive cost improvements and enhance earnings quality. However, we remain focused on the decelerating trends in athenaCollector physician adds. athenaCollector represents around 90% of revenues, and we believe there will need to be an improvement in the 15.5% YoY growth in athenaCollector physician adds in order for management to achieve their stated long-term revenue growth target of 30%+."Goldman Sachs maintains its Neutral rating and has raised the price target from $29 to $41.athenahealth, Inc. closed yesterday at $38.55.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorPrice TargetAnalyst RatingsathenahealthGoldman SachsHealth CareHealth Care Services